Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACE: Aprepitant in Cisplatin-Etoposide for Lung Cancer
NCT00588835Phase 4Terminated
- Sponsor
- Radboud University Medical Center
- Start
- Mar 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of aprepitant in chemotherapy-induced nausea and vomiting (CINV), sponsored by Radboud University Medical Center. Started Mar 2008; status: terminated.
02
Drugs
aprepitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT00588835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00588835.